Sean F. Scanlan

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

TMCI

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Treace Medical Concepts, Inc. (TMCI)	Chief Innovation Officer	$446,370	—	$1,849,688	—	—	$14,837	$2,310,894
2024	Treace Medical Concepts, Inc. (TMCI)	Chief Innovation Officer	$419,262	—	$2,189,645	$437,956	$26,235	$12,337	$3,085,435
2023	Treace Medical Concepts, Inc. (TMCI)	Chief Innovation Officer	$380,630	—	$1,898,436	$549,683	$109,500	$11,629	$2,949,878
2022	Treace Medical Concepts, Inc. (TMCI)	Chief Innovation Officer	$321,370	—	$203,397	$607,841	$195,000	$10,574	$1,338,182

No earnings-call appearances or filed executive changes recorded yet.